ARMISTICE CAPITAL, LLC - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,379,500
-22.0%
4,178,000
+15.3%
0.50%
-17.3%
Q2 2023$41,494,800
+52.7%
3,624,000
+2.8%
0.60%
+53.5%
Q1 2023$27,170,040
+31.2%
3,524,000
+3.8%
0.39%
+8.3%
Q4 2022$20,715,600
+3.0%
3,396,0000.0%0.36%
+3.4%
Q3 2022$20,104,000
+32.7%
3,396,000
+32.4%
0.35%
+32.2%
Q2 2022$15,153,000
-0.6%
2,564,000
+28.2%
0.26%
-10.5%
Q1 2022$15,240,000
+55.9%
2,000,000
-46.2%
0.30%
+77.7%
Q3 2021$9,773,000
-36.3%
3,716,0000.0%0.17%
-39.6%
Q2 2021$15,347,000
-12.3%
3,716,0000.0%0.28%
-31.6%
Q1 2021$17,502,000
-27.8%
3,716,000
+9.6%
0.40%
-51.3%
Q4 2020$24,253,000
-15.8%
3,392,000
+25.6%
0.82%
-21.1%
Q3 2020$28,809,000
+9.9%
2,700,000
+29.9%
1.04%
-9.1%
Q2 2020$26,224,000
+28.2%
2,078,000
-7.1%
1.15%
-9.1%
Q1 2020$20,459,000
-9.7%
2,236,000
+37.7%
1.26%
-3.2%
Q4 2019$22,655,000
+20.1%
1,624,000
+48.2%
1.31%
+4.6%
Q3 2019$18,862,000
-26.0%
1,096,000
+17.1%
1.25%
-22.2%
Q2 2019$25,478,000
-13.3%
936,000
-39.1%
1.61%
-0.2%
Q1 2019$29,399,000
+10.3%
1,536,000
-45.8%
1.61%
-20.3%
Q4 2018$26,658,000
-18.3%
2,836,000
+64.5%
2.02%
+3.2%
Q3 2018$32,618,000
+286.4%
1,724,000
+299.1%
1.96%
+255.4%
Q2 2018$8,441,000432,0000.55%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,851,507$29,849,1791.01%
ARMISTICE CAPITAL, LLC 4,178,000$32,379,5000.50%
SummerHaven Investment Management, LLC 72,779$564,0370.41%
GLOBEFLEX CAPITAL L P 453,595$3,515,3610.41%
Ikarian Capital, LLC 305,857$2,370,3920.28%
Hillsdale Investment Management Inc. 367,590$2,848,8240.26%
SILVERARC CAPITAL MANAGEMENT, LLC 103,966$805,7370.24%
Parkman Healthcare Partners LLC 60,322$467,4960.09%
Inspire Investing, LLC 82,656$640,5840.08%
HUSSMAN STRATEGIC ADVISORS, INC. 52,500$406,8750.08%
View complete list of VOYAGER THERAPEUTICS INC shareholders